TLRY
Tilray Brands, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$4.50
−0.66%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.54x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.38x
- Price / sales
- 0.54x
- Price / cash flow
- -8.44x
Enterprise value
- Enterprise value
- $766.8M
- EV / sales
- 0.66x
- EV / EBITDA
- 47.29x
- EV / EBIT
- -12.81x
- Market cap
- $619.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of May 1, 2026